The largest database of trusted experimental protocols

16 protocols using lightswitch assay reagent

1

Quantifying miR-203 Regulation Using Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 cells were seeded in 96-well white and clear (to confirm the density of cells) TC plates in a total volume of 100 μL. The synthetic miRNA Target GoClone reporter hsa-miR-203 (SwitchGear Genomics, CA, USA) was used as a target vector, and EMPTY_3UTR, Empty vector (no 3′UTR) (SwitchGear Genomics) was used as a control vector. miCENTURY OX miNatural, has-miR-203 (Cosmo Bio, Tokyo, Japan) was used as the synthetic miR-203. miCENTURY OX miNatural, microRNA control, non-target RNA (Cosmo Bio) was used as the control. miNatural and miRCURY LNA microRNA Inhibitor, hsa-miR-203 (Exiqon, Vedbaek, Denmark) was used as an inhibitor of miR-203. miNatural and miRCURY LNA microRNA inhibitor, antisense control A (Exiqon) was used as the control. Individual vectors and microRNAs were mixed with serum-free media, and Lipofectamine 2000 reagent (Thermo Fisher Scientific) was diluted with Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific). The final concentrations of synthetic miR-203 controls were 0, 5, 10, 20, and 40 nM, and those of the inhibitor of miR-203 was 40 and 80 nM. The concentration of each control was 40 nM. One hundred microliters of the mixture were added to each well and incubated for 24 h. Luciferase activity was measured using LightSwitch Assay Reagents (SwitchGear Genomics) and Luminescencer JNR IKB2300 (ATTO, Tokyo, Japan) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
2

Validation of miRNA-target interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confirmation of miR-149-binding to the 3′ UTR of ABCC3 and of miR-378 and miR-422-binding to the 3′ UTR of TMEM45B. HEK 293 cells at 80% confluency were co-transfected with luciferase reporter plasmids harboring the complete 3′-UTR of the desired gene (SwitchGear Genomics) along with 100 nM of each miR-mimic or miRNA control (Sigma). DharmaFECT Duo (Thermo Scientific) was used as the transfection reagent in Opti-MEM (Life Technologies). Luminescence was assayed 24 hours later using LightSwitch Assay Reagents (SwitchGear Genomics) according to the manufacturer’s instructions. Knockdown was assessed by calculating luciferase signal ratios for specific miRNA/non-targeting control, using empty reporter vector as control for non-specific effects. Each experiment was performed in triplicate. t -test was performed for wells from multiple experiments, and we compared mimic-transfected cells with a mimic control for each gene vector.
+ Open protocol
+ Expand
3

Validating miR-107-CCND1 mRNA Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Confirmation of miR-107-binding to the 3′-UTR of CCDN1. HEK 293 cells at 80% confluency were co-transfected with luciferase reporter plasmids harboring the complete 3′-UTR of the desired gene (SwitchGear Genomics) along with 100nM of miR107-mimic or miRNA control (Sigma). DharmaFECT Duo (Thermo Scientific) was used as the transfection reagent in Opti-MEM (Life Technologies). Luminescence was assayed 24 hours later using LightSwitch Assay Reagents (SwitchGear Genomics) according to the manufacturer's instructions. Knockdown was assessed by calculating luciferase signal ratios for specific miRNA/non-targeting control, using empty reporter vector as control for non-specific effects. Each experiment was performed in triplicate
+ Open protocol
+ Expand
4

Characterizing FUT8 Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FUT8 promoter was cloned from human genomic cDNA using Q5 Hotstart Polymerase (New England Biolabs) and inserted into the pLightSwitch-Prom reporter vector (SwitchGear Genomics) using the forward primer 5′-TTTCAGTTGGAAGGAGGTAGGG-3′, and reverse primer 5′-CCGCTCGGACTCGGA-3′. Plasmids were purified using Endo-Free Plasmid Maxi Kit (Qiagen). HEK 293/T17 cells (1.26 × 104) were co-transfected with plasmid (250 ng) and siRNA (60 nM) using Lipofectamine 2000 and plated in a well of a 96-well plate (100 μL total volume). After 24 hr, the assay was developed with the LightSwitch Assay Reagent (SwitchGear Genomics), and luminescence read on a Biotek microplate reader. For each assay, we calculated the average fold change as a ratio (siRNA TGIF2)/(siRNA negative control) for six replicate wells per condition. Data presented represents the average of three independent assays.
+ Open protocol
+ Expand
5

Luciferase Assay for miR-363/LATS2 Relationship

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase reporter assay was carried out as described elsewhere [43 (link)] to test the miR-363/LATS2 relationship. The firefly luciferase reporter gene expression vector, controlled with SV40 enhancer, was purchased from GeneCopoeia. The wild-type or mutant LATS2 3′-UTR sequence (LATS2; NM_014572; HmiT007288-MT06) was inserted downstream of the luciferase gene, whereas no oligonucleotides were inserted in the control vector. Renilla luciferase was used as a tracking indicator for transfection efficiency. The luciferase activity was measured using Light Switch Assay Reagent according to the manufacturer’s instructions (Switch Gear Genomics).
+ Open protocol
+ Expand
6

Validating miR-7844-5p mRNA Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
To further explore the potential targets of miR-7844-5p, in silico target scan analyses were conducted. However, it is well-established that in silico miRNA target prediction is not always valid and accurate. Therefore, we utilized a luciferase reporter assay-based approach that we and others have previously described to validate specific miR-7844-5p mRNA targets from mRNAs of interest.22 (link) The cell-based screen was conducted using a custom panel of a total of 19 validated LightSwitch 3ʹ untranslated region (UTR) GoClone reporter vectors (Active Motif, Carlsbad, CA, USA), including 6 previously established human endogenous 3ʹ UTR GoClones, 9 custom cloned 3ʹ UTRs, a synthetic miR-7844-5p target as a positive control, and 3 controls including housekeeping controls and an empty vector. Human embryonic kidney (HEK) 293T/17 cells (7 × 104) were co-transfected with a reporter vector (250 ng) and miR-7844-5p mimic (60 nM). After 24 h, the assay was developed with the LightSwitch Assay Reagent (SwitchGear Genomics, Menlo Park, CA, USA), and luminescence was analyzed using the average of 3 independent assays.
+ Open protocol
+ Expand
7

Quantifying TWIST1 Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 5000 cells per well in an opaque 96-well plate. 24 hrs later, cells were transfected with 50ng of TWIST1-promoter or control-promoter luciferase vector (SwitchGear Genomics, Menlo Park, CA) using Fugene-6 (Roche, San Francisco, CA). Luciferase activity was assayed 24 hrs later, using LightSwitch Assay Reagent (SwitchGear Genomics) and a GloMax-Multi+ Detection System with Instinct Software (Promega). Relative luciferase expression was calculated as a percent maximum of the highest sample in each group.
+ Open protocol
+ Expand
8

Luciferase Assay for LATS2, CCND1, HRAS, KRAS, XIAP

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the translation of LATS2, luciferase reporter assay was carried out as described elsewhere [45 (link)]. The wild-type (NM_014572) or mutant LATS2 3’-UTR sequence was inserted downstream of the firefly luciferase reporter gene, which was controlled by the SV40 enhancer for expression in mammalian cells, whereas no oligonucleotides were inserted in the control vector (Genecopoeia, Rockville, MD, USA). Renilla luciferase was used as a tracking indicator for successful transfection. In order to investigate the transcription of CCND1, HRAS, KRAS and XIAP, luciferase reporter constructs for the promoters of these molecules and a positive control of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained (SwitchGear Genomics, Menlo Park, CA, USA). The luciferase activity was measured using LightSwitch Assay Reagent (SwitchGear Genomics) according to the manufacturer's instructions. Briefly, 1.0 to 1.5 × 104 cells were seeded in white 96–well plates on day 1 and transfected with reporter constructs on day 2 using FuGENE HD (Promega). The luciferase activity was measured using assay reagent 48 hours after transfection.
+ Open protocol
+ Expand
9

Validating miR-92 Regulation of LATS2 via Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A luciferase reporter assay was used to test the miR-92/LATS2 relationship. The firefly luciferase reporter gene expression vector, controlled with the SV40 enhancer, was purchased from GeneCopoeia. The wild-type or mutant LATS2 3’-UTR sequence (LATS2; NM_014572; HmiT007288- MT06) was inserted downstream of the luciferase gene, whereas no oligonucleotides were inserted in the control vector. Renilla luciferase was used as a tracking indicator for transfection efficiency. The luciferase activity was measured using a LightSwitch Assay Reagent according to the manufacturer’s instructions (SwitchGear Genomics).
+ Open protocol
+ Expand
10

TWIST1 Promoter Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 5000 cells per well in an opaque 96-well plate. After 24 h, cells were transfected with 50 ng of TWIST1 promoter or control promoter luciferase vector (SwitchGear Genomics, Menlo Park, CA, USA) using Fugene-6 (Roche, San Francisco, CA, USA). Luciferase activity was assayed 24 h later, using LightSwitch Assay Reagent (SwitchGear Genomics) and a GloMax-Multi+ Detection System with Instinct Software (Promega, Madison, WI, USA). Relative luciferase expression was calculated as a percent maximum of the highest sample in each group.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!